Related Experiment Video
Updated: May 12, 2026

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT
Yen-Rong Chen1, Keisuke Sekine, Koji Nakamura
1Institute of Molecular and Cellular Biosciences, The University of Tokyo, Japan.
Insights
Y-box binding protein-1 (YB-1) inhibits carbamoyl phosphate synthetase-I (CPS1) expression, impacting ammonia detoxification. This study reveals YB-1
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Carbamoyl phosphate synthetase-I (CPS1) is crucial for urea cycle function; defects lead to hyperammonemia.
- CPS1 liver expression is regulated by CCAAT enhancer-binding protein-alpha (C/EBPalpha) but is absent in fetal liver.
Purpose of the Study:
- To elucidate the regulatory mechanism of CPS1 expression, particularly the factor involved in its absence in fetal liver.
Main Methods:
- Microarray analysis identified Y-box binding protein-1 (YB-1) in mouse fetal liver.
- Investigated YB-1's role in CPS1 regulation through overexpression studies and luciferase reporter assays.
- Chromatin immunoprecipitation (ChIP) assays examined YB-1 recruitment to the CPS1 promoter in vivo.
Main Results:
- YB-1 expression inversely correlated with CPS1 expression; YB-1 inhibited CPS1 and ammonia clearance in fetal liver.
- Acute liver injury induced YB-1, suppressed CPS1, and increased serum ammonia levels.
- YB-1 suppressed C/EBPalpha-mediated CPS1 transcription and was recruited to the CPS1 promoter in fetal and injured adult liver.
Conclusions:
- Y-box binding protein-1 (YB-1) acts as a key regulator of ammonia detoxification.
- YB-1 negatively regulates CPS1 expression by suppressing C/EBPalpha function.
Background & Aims:
Carbamoyl phosphate synthetase-I (CPS1) is a key enzyme in the urea cycle and patients with defects in the function or expression of CPS1 suffer from hyperammonemia. CPS1 is expressed in the liver at neonatal and adult stages in a CCAAT enhancer-binding protein-alpha (C/EBPalpha)-dependent manner. Despite expression of C/EBPalpha, CPS1 is not expressed in fetal liver, indicating an additional factor is involved in the regulation of CPS1 expression. The aim of this study was to elucidate the mechanism of CPS1 expression.
Methods:
Microarray was performed to find Y-box binding protein-1 (YB-1) that was expressed in mouse fetal liver. The role of YB-1 in CPS1 expression was investigated by overexpression of YB-1 in mouse fetal liver culture and luciferase reporter assays using the CPS1 promoter. Chromatin immunoprecipitation assay was used to examine recruitment of YB-1 to the CPS1 promoter in vivo.
Results:
Expression of YB-1 and CPS1 was inversely correlated in vivo, and YB-1 inhibited CPS1 expression and ammonia clearance in fetal liver culture. Although YB-1 was not expressed in adult liver, acute liver injury up-regulated YB-1 and down-regulated CPS1, accompanying an increase of the serum ammonia level. YB-1 inhibited C/EBPalpha-induced transcription from the CPS1 promoter via the Y-box near the C/EBPalpha-binding site. Chromatin immunoprecipitation assays demonstrated that YB-1 was recruited to the CPS1 promoter in fetal and injured adult liver, but not in normal adult liver.
Conclusions:
YB-1 is a key regulator of ammonia detoxification by negatively regulating CPS1 expression via suppression of C/EBPalpha function.
Related Concept Videos
Epigenetic Regulation
RNA Polymerase II Accessory Proteins
Cell Specific Gene Expression
Master Transcription Regulators
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Epigenetic Regulation
X-chromosome...

